MILIC, Jovana
 Distribuzione geografica
Continente #
NA - Nord America 6.040
EU - Europa 3.583
AS - Asia 3.368
SA - Sud America 413
AF - Africa 129
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.571
Nazione #
US - Stati Uniti d'America 5.792
IT - Italia 1.423
SG - Singapore 1.037
CN - Cina 777
GB - Regno Unito 507
HK - Hong Kong 387
VN - Vietnam 339
SE - Svezia 305
BR - Brasile 300
DE - Germania 243
FI - Finlandia 213
RU - Federazione Russa 189
FR - Francia 182
CA - Canada 175
BD - Bangladesh 155
IN - India 114
KR - Corea 114
NL - Olanda 76
ID - Indonesia 70
ES - Italia 68
JP - Giappone 55
MX - Messico 45
ZA - Sudafrica 44
BG - Bulgaria 42
AR - Argentina 41
TR - Turchia 41
CH - Svizzera 39
IQ - Iraq 39
SI - Slovenia 38
AE - Emirati Arabi Uniti 31
BE - Belgio 29
IE - Irlanda 29
UA - Ucraina 29
AU - Australia 28
IR - Iran 28
PK - Pakistan 28
PL - Polonia 25
LT - Lituania 23
PH - Filippine 23
RO - Romania 22
SA - Arabia Saudita 22
UG - Uganda 22
CO - Colombia 20
MY - Malesia 18
EG - Egitto 15
TW - Taiwan 15
RS - Serbia 14
EC - Ecuador 13
VE - Venezuela 13
CL - Cile 12
NO - Norvegia 12
GR - Grecia 11
IL - Israele 11
UZ - Uzbekistan 11
AT - Austria 10
AZ - Azerbaigian 9
MA - Marocco 9
CZ - Repubblica Ceca 8
KE - Kenya 8
LB - Libano 7
AL - Albania 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PE - Perù 6
TN - Tunisia 6
ET - Etiopia 5
HR - Croazia 5
JM - Giamaica 5
KG - Kirghizistan 5
PT - Portogallo 5
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
NP - Nepal 4
PY - Paraguay 4
BY - Bielorussia 3
CG - Congo 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
JO - Giordania 3
LU - Lussemburgo 3
MK - Macedonia 3
NG - Nigeria 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
MC - Monaco 2
MD - Moldavia 2
PA - Panama 2
Totale 13.544
Città #
Ashburn 697
Singapore 669
Santa Clara 658
Chandler 443
Fairfield 431
Hong Kong 358
San Jose 299
Hefei 253
Woodbridge 228
Nyköping 219
Helsinki 195
Seattle 177
Southend 171
London 161
Council Bluffs 159
Houston 153
Cambridge 150
New York 145
Wilmington 130
Modena 129
Beijing 124
Dallas 119
Milan 117
Ho Chi Minh City 116
Los Angeles 111
Rome 102
Seoul 98
Bologna 87
The Dalles 83
Hanoi 79
Chicago 70
Lauterbourg 60
San Diego 56
Ann Arbor 55
Jakarta 53
Toronto 52
Frankfurt am Main 48
Munich 48
Shanghai 47
Buffalo 44
Dearborn 44
Moscow 39
Princeton 39
Sofia 39
Tokyo 39
North York 38
São Paulo 36
St. Petersburg 35
Boardman 34
Montreal 29
Bremen 28
Amsterdam 27
Dublin 26
Zarautz 26
Brussels 25
Florence 25
Orem 24
Salt Lake City 24
Phoenix 23
Roncoferraro 22
Jacksonville 21
Piacenza 21
Denver 20
Kampala 20
Vinovo 20
Chennai 19
Naples 19
Düsseldorf 18
Nuremberg 18
Portsmouth 18
Cape Town 17
Dammam 17
Redwood City 17
Sydney 17
Brooklyn 16
Bucharest 16
Eugene 16
Mexico City 16
Parma 16
Stockholm 16
Atlanta 15
Kent 15
Perugia 15
Warsaw 15
Baghdad 14
Beauharnois 14
Isfahan 14
Poplar 14
Secaucus 14
Birmingham 13
Johannesburg 13
Paris 13
Redondo Beach 13
Tampa 13
Haiphong 12
Monza 12
Seriate 12
Da Nang 11
Dong Ket 11
Dubai 11
Totale 8.638
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 514
Data-driven vs knowledge-driven inference of health outcomes in the ageing population: A case study 449
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 437
La sarcopenia nell’anziano con HIV 427
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS 365
Machine learning algorithm to predict weight change in ART experienced PWH 355
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 343
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 340
Changes in central adipose tissue after switching to integrase inhibitors 330
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 324
The interplay between frailty and intrinsic capacity in aging and HIV infection 320
Non–alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV 318
The pathway of NAFLD vs MAFLD toward significant fibrosis 313
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 311
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 308
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 290
Predicting Respiratory Failure in Patients with COVID-19 pneumonia: a case study from Northern Italy 288
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 281
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients 262
From NAFLD to MAFLD: implications of change in terminology in PWH 260
What is the measure of success in HIV? The fourth 90: quality of life or healthy aging? 256
Machine learning algorithm to predict >5% weight gain in PWH switching to INSTI 256
The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV 243
Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure 243
Managing antiretroviral therapy in the elderly HIV patient 241
Thymus Imaging Detection and Size Is Inversely Associated With Metabolic Syndrome and Frailty in People With HIV 239
The Interplay Between Age and Frailty in People Living With HIV: Results From an 11-Year Follow-up Observational Study 230
Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era 228
Machine learning algorithm to predict >5% Weight Gain in PWH switching to InSTI 227
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV 226
Sex Differences in People Aging With HIV 222
Relazioni chiave tra steatosi epatica, insulino-resistenza, diabete mellito, fragilità, terapia antiretrovirale basata sugli inibitori dell'integrasi e aumento di peso nelle persone che vivono con HIV 221
Non-alcoholic to metabolic associated fatty liver disease: Cardiovascular implications of a change in terminology in patients living with HIV 220
Aging with HIV 217
Relationship between weight gain and insulin resistance in people living with HIV switching to INSTI-based regimens 209
Characteristics of long COVID among older adults: a cross-sectional study 205
Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV 199
From NAFLD to MAFLD: implications of change in terminology in PWH 196
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons 192
The pathway of NAFLD vs MAFLD toward significant fibrosis 189
Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life 188
AKI in hospitalized patients with COVID-19: a single-center experience 184
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 182
Impact of prolonged maraviroc treatment on non-AIDS-related comorbidities in HIV-positive patients: a retrospective cohort study 177
Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway 158
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 142
Why am I getting fat? Exploring immune-metabolic pathways to central fat accumulation in persons with HIV 142
Primary, secondary and compensated male biochemical hypogonadism in people living with HIV (PLWH): relevance of sex hormone-binding globulin (SHBG) measurement and comparison between liquid chromatography-tandem mass spectrometry (LC-MS/MS) and chemiluminescent immunoassay for sex steroids assay 142
Vitamin e as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: What is waiting on the other side of the bridge? 134
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 131
A Metabolic Health Framework to Interpret Weight Gain Studies in People With Human Immunodeficiency Virus 117
Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia 115
Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients 106
Late HIV diagnosis - a tale of successes and failures 87
Distilling Clinical Scores with Symbolic Machine Learning: Frailty Index, an HIV Cohort Case Study 78
Prevalence and risk factors of cognitive frailty in people with HIV 67
Bimonthly Administered Long-Acting Cabotegravir and Rilpivirine Are Highly Effective and Well-Tolerated in People With Human Immunodeficiency Virus Above 65 Years 66
Association Between Reduced Daily Protein Intake and Sarcopenic Obesity in Men Living with HIV: A New Screening Tool 54
A Machine learning approach to predict Weight change in ART experienced PLWH 44
Introducing the WHO ICOPE approach into HIV care: A perspective on healthy ageing in people living with HIV 27
Health profiles of foreign-born elderly women with HIV in Italy 25
A multidisciplinary, AI‐supported quality improvement intervention to manage polypharmacy in aging people with HIV. 21
FIB-4 fails to identify significant liver fibrosis in people with HIV: A large multinational screening study 7
Cognitive and fine motor performance in people above 65 years of age with and without HIV 6
Totale 13.694
Categoria #
all - tutte 53.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 0 0 120
2021/2022963 86 46 58 64 52 92 37 50 102 98 171 107
2022/20231.831 158 227 195 153 194 158 117 177 167 39 140 106
2023/20241.251 70 99 79 154 170 131 92 110 49 56 98 143
2024/20252.647 84 65 69 194 469 389 180 141 358 165 224 309
2025/20265.097 371 234 356 585 757 363 633 248 477 459 380 234
Totale 13.694